BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 34399524)

  • 41. Experimental Animal Studies Support the Role of Dietary Advanced Glycation End Products in Health and Disease.
    Peppa M; Mavroeidi I
    Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Advanced Glycation End-Products and Excessive Calorie Intake on Diet-Induced Chronic Low-Grade Inflammation Biomarkers in Murine Models.
    Nogueira Silva Lima MT; Howsam M; Anton PM; Delayre-Orthez C; Tessier FJ
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dietary glycemic load is associated with higher concentrations of urinary advanced glycation endproducts: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study.
    Maasen K; van Greevenbroek MMJ; Scheijen JLJM; van der Kallen CJH; Stehouwer CDA; Schalkwijk CG
    Am J Clin Nutr; 2019 Aug; 110(2):358-366. PubMed ID: 31240298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advanced Glycation End Products (AGEs) in Diet and Skin in Relation to Stool Microbiota: The Rotterdam Study.
    Chen J; Radjabzadeh D; Medina-Gomez C; Voortman T; van Meurs JBJ; Ikram MA; Uitterlinden AG; Kraaij R; Zillikens MC
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Habitual intake of dietary advanced glycation end products is not associated with generalized microvascular function-the Maastricht Study.
    Linkens AMA; Houben AJHM; Kroon AA; Schram MT; Berendschot TTJM; Webers CAB; van Greevenbroek M; Henry RMA; de Galan B; Stehouwer CDA; Eussen SJMP; Schalkwijk CG
    Am J Clin Nutr; 2022 Feb; 115(2):444-455. PubMed ID: 34581759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential Effects of Dietary Patterns on Advanced Glycation end Products: A Randomized Crossover Study.
    Kim Y; Keogh JB; Deo P; Clifton PM
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32545555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary advanced glycation endproducts (AGEs) increase their concentration in plasma and tissues, result in inflammation and modulate gut microbial composition in mice; evidence for reversibility.
    van Dongen KCW; Linkens AMA; Wetzels SMW; Wouters K; Vanmierlo T; van de Waarenburg MPH; Scheijen JLJM; de Vos WM; Belzer C; Schalkwijk CG
    Food Res Int; 2021 Sep; 147():110547. PubMed ID: 34399524
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advanced glycation endproducts in food and their effects on health.
    Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
    Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology.
    Snelson M; Coughlan MT
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30678161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective.
    Thornalley PJ; Rabbani N
    Biochim Biophys Acta; 2014 Feb; 1840(2):818-29. PubMed ID: 23558060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of gut microbiota in the modulation of the health effects of advanced glycation end‑products (Review).
    Aschner M; Skalny AV; Gritsenko VA; Kartashova OL; Santamaria A; Rocha JBT; Spandidos DA; Zaitseva IP; Tsatsakis A; Tinkov AA
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37052251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary Advanced Glycation End Products and Cardiometabolic Risk.
    Luévano-Contreras C; Gómez-Ojeda A; Macías-Cervantes MH; Garay-Sevilla ME
    Curr Diab Rep; 2017 Aug; 17(8):63. PubMed ID: 28695383
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.